Yuliang Wang

机构：Jiamusi University, Chinese University of Hong Kong, Shanghai Jiao Tong University, Xiamen University, First Affiliated Hospital of Xiamen University, Biotechnology Research Center, National Clinical Research Center for Digestive Diseases, Nanjing Brain Hospital, Chinese University of Hong Kong, Shenzhen, Lanzhou University Second Hospital, Chengdu Tool Research Institute (China), First Affiliated Hospital Zhejiang University, Lanzhou University, Nanjing Medical University, University of Hong Kong · ORCID：0000-0001-6975-4503

发表论文 156 篇 · 总被引 2661 次 · h-index 30

代表论文

• Targeting JMJD1C to selectively disrupt tumor Treg cell fitness enhances antitumor immunity (2024 · Nature Immunology · 被引 44)
• GJB2 Promotes HCC Progression by Activating Glycolysis Through Cytoplasmic Translocation and Generating a Suppressive Tumor Microenvironment Based on Single Cell RNA Sequencing (2024 · Advanced Science · 被引 24)
• Nuclear receptor NURR1 functions to promote stemness and epithelial-mesenchymal transition in prostate cancer via its targeting of Wnt/β-catenin signaling pathway (2024 · Cell Death and Disease · 被引 20)
• Estrogen-related receptor alpha (ERRα) controls the stemness and cellular energetics of prostate cancer cells via its direct regulation of citrate metabolism and zinc transportation (2025 · Cell Death and Disease · 被引 12)
• Sex differences in the association of wearable accelerometer-derived physical activity with coronary heart disease incidence and mortality (2025 · Nature Cardiovascular Research · 被引 9)
• Revitalizing Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches (2024 · Pharmaceutics · 被引 8)